Trial Profile
The Use of Recombinant hCG to Prevent Breast Cancer in BRCA1 and BRCA2 Carriers
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Choriogonadotropin alfa (Primary)
- Indications Breast cancer
- Focus Pharmacodynamics; Pharmacogenomic
- 26 Aug 2019 Status changed from recruiting to completed.
- 16 Apr 2018 New trial record